Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtech industry mostly confident about 2009, suggests global survey

This article was originally published in Clinica

Executive Summary

Medical device and in vitro diagnostics companies globally remain positive about business in 2009, despite the global economic downturn, according to a survey conducted earlier this month. US consultancy Emergo Group (Austin, Texas) reports that 74% of the company representatives interviewed said their firms were planning to expand into international markets next year. 56% said they were positive about their firm’s prospects in 2009, and 61% expected their overall sales to increase. Just 9% expected a decrease in sales from 2008, and 17% stated that they were either “somewhat negative” or “very negative” about the coming year. The survey involved executives from more than 1,000 companies in North America (67%), Europe (18%) and Asia (10%). Small firms, of less than 100 employees. made up 60% of the respondents.

You may also be interested in...

Asia Regulatory Forum Update

Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.

Saudi Arabia adopts interim device authorisation regulation

Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.

Canada takes action to increase more adverse event reporting

The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts